Central Garden & Pet reported a solid second quarter with sales increasing by 4.4% to $703.2 million and diluted EPS increasing to $0.78. The growth was driven by recent acquisitions, despite challenges posed by COVID-19. Full year 2020 guidance was suspended due to the pandemic.
Total net sales increased 4.4% to $703.2 million compared to the second quarter a year ago, driven in large part by recent acquisitions.
The diluted earnings per share for the quarter was $0.78 compared to $0.73 in the prior year quarter.
Second quarter net sales for the Pet segment rose 6.7% to $360.8 million compared to the same period a year ago, aided by the Company's C&S acquisition.
Second quarter net sales for the Garden segment rose 2.1% to $342.4 million, driven by the Arden acquisition.
Given the unprecedented uncertainty of the global COVID-19 crisis, including the lack of clarity into the future and the rapid pace of change, the Company is suspending providing guidance for fiscal 2020 until the COVID-19 situation in the US stabilizes.
Visualization of income flow from segment revenue to net income